0001472343-16-000238.txt : 20161110
0001472343-16-000238.hdr.sgml : 20161110
20161110161633
ACCESSION NUMBER: 0001472343-16-000238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161110
FILED AS OF DATE: 20161110
DATE AS OF CHANGE: 20161110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Roka BioScience, Inc.
CENTRAL INDEX KEY: 0001472343
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 270881542
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1216
BUSINESS ADDRESS:
STREET 1: 20 INDEPENDENCE BOULEVARD
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-605-4700
MAIL ADDRESS:
STREET 1: 20 INDEPENDENCE BOULEVARD
CITY: WARREN
STATE: NJ
ZIP: 07059
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boesgaard Lars
CENTRAL INDEX KEY: 0001403893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36538
FILM NUMBER: 161988245
MAIL ADDRESS:
STREET 1: C/O ROKA BIOSCIENCE, INC.
STREET 2: 20 INDEPENDENCE BOULEVARD
CITY: WARREN
STATE: NJ
ZIP: 07059
4
1
wf-form4_147881257960648.xml
FORM 4
X0306
4
2016-11-10
0
0001472343
Roka BioScience, Inc.
ROKA
0001403893
Boesgaard Lars
20 INDEPENDENCE BLVD
WARREN
NJ
07059
0
1
0
0
Vice President, CFO
Common Stock, $0.001 par value per share
2016-11-10
4
C
0
3572
7
A
8938
D
Series A Convertible Preferred Stock
2016-11-10
4
C
0
25
0
D
Common stock, par value $0.001 per share
3572.0
0
D
Reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Shares") automatically converted into shares of the Company's common stock, par value $0.001 (the "Common Shares") at a conversion price of $7.00 per share resulting in his acquisition of 3,572 Common Shares. Common Shares disclosed reflect the October 11, 2016, 10 for 1 reverse stock split of the Company's Common Shares. The Series A Preferred Shares were adjusted proportionately and consequently, each share of Preferred Stock became convertible into approximately 143 shares of common stock.
The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date.
/s/ Corey Swanson, attorney-in-fact
2016-11-10